3B Blackbio Dx profitability ratios

Per cent unless marked ×
Tap a line for its trendFY25Mar 2025FY24Mar 2024
Returns
19.0%15.0%
17.4%13.7%
19.2%14.7%
13.7%11.4%
Margins
55.1%49.6%
54.1%48.4%
74.5%—
70.6%65.7%
52.5%48.4%
49.1%40.3%
Additional
25.6%26.3%
19.0%15.0%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

3BBLACKBIO₹1,359.20

3B Blackbio Dx Limited

· Pharma & Health
₹ CrorePeersHEALTHXSURAKSHAKRSNAANEPHROPLUS
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
Returns
Return on Common Equity15.0219.00
Return on Assets13.7017.39
Return on Capital Employed14.7119.15
Return on Invested Capital11.3613.67
Margins
EBITDA Margin49.6455.07
Operating Margin48.4154.12
Incremental Operating Margin—74.52
Pretax Margin65.6770.61
Net Income Margin48.3852.53
FCF Margin40.2549.12
Additional
Effective Tax Rate26.3225.56
Sustainable Growth Rate15.0219.00
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY25 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.